TAFA1
gene geneOn this page
Also known as TAFA-1
Summary
TAFA1 (TAFA chemokine like family member 1, HGNC:21587) is a protein-coding gene on chromosome 3p14.1, encoding Chemokine-like protein TAFA-1 (Q7Z5A9). Regulatory factor which is ligand for CMKLR2 and is involved in the modulation of neural stem-cell proliferation and differentiation.
This gene is a member of the TAFA family which is composed of five highly homologous genes that encode small secreted proteins. These proteins contain conserved cysteine residues at fixed positions, and are distantly related to MIP-1alpha, a member of the CC-chemokine family. The TAFA proteins are predominantly expressed in specific regions of the brain, and are postulated to function as brain-specific chemokines or neurokines that act as regulators of immune and nervous cells.
Source: NCBI Gene 407738 — RefSeq curated summary.
At a glance
- GWAS associations: 7
- Clinical variants (ClinVar): 16 total
- MANE Select transcript:
NM_213609
Identifiers
Gene identifiers
| Field | Value |
|---|---|
| HGNC ID | HGNC:21587 |
| Approved symbol | TAFA1 |
| Name | TAFA chemokine like family member 1 |
| Location | 3p14.1 |
| Locus type | gene with protein product |
| Status | Approved |
| Aliases | TAFA-1 |
| Ensembl gene | ENSG00000183662 |
| Ensembl biotype | protein_coding |
| OMIM | 617495 |
| Entrez | 407738 |
Gene structure
Transcript identifiers
Ensembl transcripts: 3 — 2 protein_coding, 1 protein_coding_CDS_not_defined
ENST00000478136, ENST00000491017, ENST00000496687
RefSeq mRNA: 2 — MANE Select: NM_213609
NM_001252216, NM_213609
CCDS: CCDS54606
Canonical transcript exons
ENST00000478136 — 5 exons
| Exon | Start | End |
|---|---|---|
| ENSE00001294156 | 68538756 | 68538880 |
| ENSE00001312175 | 68417280 | 68417420 |
| ENSE00001816274 | 68544486 | 68545621 |
| ENSE00001853594 | 68006624 | 68006744 |
| ENSE00001941850 | 68004247 | 68004702 |
Expression profiles
Bgee: expression breadth ubiquitous, 157 present calls, max score 96.29.
FANTOM5 (CAGE): breadth tissue_specific, TPM avg 2.5273 / max 388.9571, expressed in 113 samples.
FANTOM5 promoters (6 alternative TSS)
| Promoter ID | TPM avg | Samples expressed |
|---|---|---|
| 37213 | 1.2204 | 94 |
| 37214 | 0.9771 | 86 |
| 37217 | 0.1622 | 45 |
| 37212 | 0.1175 | 25 |
| 37216 | 0.0329 | 21 |
| 37215 | 0.0172 | 10 |
Top tissues by expression
247 total, by Bgee expression score (0-100, higher = more expressed):
| Tissue | Anatomy ID | Expression score | Quality |
|---|---|---|---|
| middle temporal gyrus | UBERON:0002771 | 96.29 | gold quality |
| endothelial cell | CL:0000115 | 95.21 | gold quality |
| Brodmann (1909) area 23 | UBERON:0013554 | 95.16 | gold quality |
| pons | UBERON:0000988 | 94.25 | gold quality |
| Brodmann (1909) area 46 | UBERON:0006483 | 91.52 | gold quality |
| superior frontal gyrus | UBERON:0002661 | 90.41 | gold quality |
| entorhinal cortex | UBERON:0002728 | 89.11 | gold quality |
| postcentral gyrus | UBERON:0002581 | 88.19 | gold quality |
| parietal lobe | UBERON:0001872 | 87.73 | gold quality |
| primary visual cortex | UBERON:0002436 | 87.68 | gold quality |
| occipital lobe | UBERON:0002021 | 86.13 | gold quality |
| dorsolateral prefrontal cortex | UBERON:0009834 | 85.82 | gold quality |
| cortical plate | UBERON:0005343 | 85.54 | gold quality |
| frontal cortex | UBERON:0001870 | 85.19 | gold quality |
| prefrontal cortex | UBERON:0000451 | 85.09 | gold quality |
| male germ line stem cell (sensu Vertebrata) in testis | CL:0000089 ∩ UBERON:0000473 | 84.68 | gold quality |
| cerebral cortex | UBERON:0000956 | 84.63 | gold quality |
| neocortex | UBERON:0001950 | 84.38 | gold quality |
| Brodmann (1909) area 9 | UBERON:0013540 | 84.04 | gold quality |
| Ammon’s horn | UBERON:0001954 | 84.01 | gold quality |
| temporal lobe | UBERON:0001871 | 82.09 | gold quality |
| right frontal lobe | UBERON:0002810 | 81.87 | gold quality |
| anterior cingulate cortex | UBERON:0009835 | 81.17 | gold quality |
| dorsal root ganglion | UBERON:0000044 | 80.03 | gold quality |
| amygdala | UBERON:0001876 | 77.16 | gold quality |
| forebrain | UBERON:0001890 | 72.98 | gold quality |
| trigeminal ganglion | UBERON:0001675 | 72.79 | gold quality |
| ventricular zone | UBERON:0003053 | 71.29 | gold quality |
| seminal vesicle | UBERON:0000998 | 70.92 | gold quality |
| ganglionic eminence | UBERON:0004023 | 70.69 | gold quality |
Single-cell (SCXA)
Detected in 4 experiment(s), a significant marker in 3.
| Experiment | Marker? | Max mean expression |
|---|---|---|
| E-HCAD-30 | yes | 1597.13 |
| E-HCAD-35 | yes | 1413.89 |
| E-HCAD-25 | yes | 81.92 |
| E-ANND-3 | no | 3.72 |
Regulation
Is transcription factor: no
miRNA regulators (miRDB)
132 targeting TAFA1, top 30 by miRDB confidence (max_score; target_count = how many genes the miRNA targets in total — lower means more specific):
| miRNA | Max score | Avg score | miRNA target_count |
|---|---|---|---|
| HSA-MIR-190A-3P | 100.00 | 80.35 | 5520 |
| HSA-MIR-5011-5P | 100.00 | 83.46 | 5820 |
| HSA-MIR-340-5P | 100.00 | 72.50 | 4437 |
| HSA-MIR-656-3P | 100.00 | 72.15 | 2788 |
| HSA-MIR-6077 | 99.99 | 68.04 | 2299 |
| HSA-MIR-371B-5P | 99.99 | 75.34 | 4759 |
| HSA-MIR-32-5P | 99.98 | 75.21 | 1964 |
| HSA-MIR-92A-3P | 99.98 | 75.21 | 1960 |
| HSA-MIR-92B-3P | 99.98 | 75.25 | 1955 |
| HSA-MIR-25-3P | 99.98 | 74.60 | 1817 |
| HSA-MIR-363-3P | 99.98 | 74.72 | 1821 |
| HSA-MIR-367-3P | 99.98 | 74.83 | 1819 |
| HSA-MIR-520D-5P | 99.98 | 73.34 | 4883 |
| HSA-MIR-524-5P | 99.98 | 73.43 | 4882 |
| HSA-MIR-373-5P | 99.98 | 75.36 | 4753 |
| HSA-MIR-616-5P | 99.98 | 75.58 | 4775 |
| HSA-MIR-607 | 99.97 | 73.62 | 5593 |
| HSA-MIR-3148 | 99.97 | 75.06 | 6478 |
| HSA-MIR-559 | 99.95 | 72.28 | 3609 |
| HSA-MIR-548AB | 99.95 | 71.31 | 3488 |
| HSA-MIR-548A-5P | 99.94 | 71.27 | 3482 |
| HSA-MIR-548AD-5P | 99.94 | 71.23 | 3502 |
| HSA-MIR-548AE-5P | 99.94 | 71.23 | 3502 |
| HSA-MIR-548AK | 99.94 | 71.24 | 3488 |
| HSA-MIR-548AM-5P | 99.94 | 71.24 | 3488 |
| HSA-MIR-548AP-5P | 99.94 | 71.14 | 3489 |
| HSA-MIR-548AQ-5P | 99.94 | 71.34 | 3426 |
| HSA-MIR-548AR-5P | 99.94 | 71.28 | 3515 |
| HSA-MIR-548AS-5P | 99.94 | 71.22 | 3482 |
| HSA-MIR-548AU-5P | 99.94 | 71.24 | 3488 |
Cross-species orthologs
3 orthologs
| Organism | Symbol | Gene ID |
|---|---|---|
| danio_rerio | tafa1a | ENSDARG00000062357 |
| mus_musculus | Tafa1 | ENSMUSG00000059187 |
| rattus_norvegicus | Tafa1 | ENSRNOG00000070575 |
Paralogs (3): TAFA4 (ENSG00000163377), TAFA3 (ENSG00000184599), TAFA2 (ENSG00000198673)
Protein
Protein identifiers
Chemokine-like protein TAFA-1 — Q7Z5A9 (reviewed: Q7Z5A9)
All UniProt accessions (1): Q7Z5A9
UniProt curated annotations — full annotation on UniProt →
Function. Regulatory factor which is ligand for CMKLR2 and is involved in the modulation of neural stem-cell proliferation and differentiation.
Subcellular location. Secreted.
Tissue specificity. Brain-specific.
Similarity. Belongs to the TAFA family.
RefSeq proteins (2): NP_001239145, NP_998774* (*=MANE)
Domains & families (InterPro)
| ID | Name | Type |
|---|---|---|
| IPR020350 | Chemokine-like_TAFA | Family |
| IPR051743 | TAFA_chemokine-like | Family |
Pfam: PF12020
UniProt features (3 total): signal peptide 1, chain 1, sequence conflict 1
Structure
Experimental structures (PDB)
0 structures.
Predicted structure (AlphaFold)
| Model | pLDDT | Fraction very-high |
|---|---|---|
| AF-Q7Z5A9-F1 | 85.90 | 0.64 |
Function
Pathways and Gene Ontology
Reactome pathways
0 pathways
MSigDB gene sets: 165 (showing top):
RNGTGGGC_UNKNOWN, FREAC2_01, HNF3ALPHA_Q6, NKX25_02, AREB6_01, GOBP_NEUROGENESIS, CREBP1_Q2, TGACCTY_ERR1_Q2, TAL1ALPHAE47_01, LHX3_01, GGGTGGRR_PAX4_03, CEBPB_01, CREB_Q4, GOBP_NEURAL_PRECURSOR_CELL_PROLIFERATION, TCF4_Q5
GO Biological Process (4): regulation of signaling receptor activity (GO:0010469), neuroblast differentiation (GO:0014016), regulation of neuroblast proliferation (GO:1902692), signal transduction (GO:0007165)
GO Molecular Function (2): receptor ligand activity (GO:0048018), protein binding (GO:0005515)
GO Cellular Component (3): obsolete extracellular space (GO:0005615), endoplasmic reticulum (GO:0005783), extracellular region (GO:0005576)
GO top-level categories
Rollup of top GO terms by namespace:
| Category | Terms |
|---|---|
| regulation of signal transduction | 1 |
| signaling receptor activity | 1 |
| regulation of molecular function | 1 |
| cell differentiation | 1 |
| generation of neurons | 1 |
| neuroblast proliferation | 1 |
| regulation of neural precursor cell proliferation | 1 |
| cell communication | 1 |
| cellular process | 1 |
| signaling | 1 |
| regulation of cellular process | 1 |
| cellular response to stimulus | 1 |
| signaling receptor binding | 1 |
| signal transduction | 1 |
| signaling receptor activator activity | 1 |
| binding | 1 |
| cytoplasm | 1 |
| endomembrane system | 1 |
| intracellular membrane-bounded organelle | 1 |
| cellular anatomical structure | 1 |
Protein interactions and networks
STRING
964 interactions, top by confidence (×1000):
| Protein A | Protein B | Partner UniProt | Score |
|---|---|---|---|
| TAFA1 | CMKLR2 | P46091 | 658 |
| TAFA1 | NECAB2 | Q7Z6G3 | 506 |
| TAFA1 | NRXN2 | Q9P2S2 | 485 |
| TAFA1 | NRXN1 | Q9ULB1 | 471 |
| TAFA1 | FAM110A | Q9BQ89 | 437 |
| TAFA1 | TMEM182 | Q6ZP80 | 420 |
| TAFA1 | FAM163A | Q96GL9 | 413 |
| TAFA1 | EFCAB10 | A6NFE3 | 404 |
| TAFA1 | TAFA5 | Q7Z5A7 | 399 |
| TAFA1 | SNX29 | Q8TEQ0 | 396 |
| TAFA1 | KCNK2 | O95069 | 391 |
| TAFA1 | STPG2 | Q8N412 | 379 |
| TAFA1 | RPAP3 | Q9H6T3 | 370 |
| TAFA1 | GLRA3 | O75311 | 363 |
| TAFA1 | SMIM13 | P0DJ93 | 362 |
IntAct
7 interactions, top by confidence:
| A | B | Type | Score |
|---|---|---|---|
| TAFA1 | RABGGTB | psi-mi:“MI:0915”(physical association) | 0.560 |
| RABGGTB | TAFA1 | psi-mi:“MI:0915”(physical association) | 0.560 |
| TAFA1 | ZER1 | psi-mi:“MI:0914”(association) | 0.530 |
| TAFA1 | M6PR | psi-mi:“MI:0914”(association) | 0.350 |
| TAFA1 | SEZ6L2 | psi-mi:“MI:0914”(association) | 0.350 |
BioGRID (10): FAM19A1 (Two-hybrid), NRXN3 (Affinity Capture-MS), ZER1 (Affinity Capture-MS), M6PR (Affinity Capture-MS), ZER1 (Affinity Capture-MS), NRXN3 (Affinity Capture-MS), NCSTN (Affinity Capture-MS), POMGNT2 (Affinity Capture-MS), PLXNA1 (Affinity Capture-MS), SEZ6L2 (Affinity Capture-MS)
ESM2 similar proteins: A0A291NVT7, A0A4Y5X186, A0A4Y5X1A7, A0A7S8RFI7, A0S864, A7X3V0, B2ZG38, B3EWX6, C0HLS6, C0HLS9, C0HLT1, C0HLT2, C0HM40, C5H8E7, C9E1S2, D3GGZ8, O12961, P01060, P01066, P05486, P0C6A4, P0DN42, P0DN43, P0DQE9, P0DTJ2, P0DTJ3, P0DUA3, P10776, P19860, P22737, P36985, P58990, P81743, Q00945, Q10037, Q2XXR7, Q2XXR8, Q3BK15, Q4R128, Q56R11
Diamond homologs: M0R7X9, Q3ZBS2, Q5R6N2, Q7TPG5, Q7TPG6, Q7TPG7, Q7TPG8, Q7Z5A7, Q7Z5A8, Q7Z5A9, Q8N3H0, Q91WE9, Q96LR4, Q9N0D3
SIGNOR signaling
0 interactions.
Disease & clinical
Clinical variants and AI predictions
ClinVar
16 variants total. Per-class counts are floors (≥ shown; pagination cap):
| Classification | Count (floor) |
|---|---|
| Pathogenic | 0 |
| Likely pathogenic | 0 |
| Uncertain significance | 16 |
| Likely benign | 0 |
| Benign | 0 |
Top pathogenic / likely-pathogenic (0)
SpliceAI
4844 predictions. Top by Δscore:
| Variant | Effect | Δscore |
|---|---|---|
| 3:68082949:G:GT | donor_gain | 1.0000 |
| 3:68378564:GAA:G | donor_gain | 1.0000 |
| 3:68378565:A:T | donor_gain | 1.0000 |
| 3:68378571:T:G | donor_gain | 1.0000 |
| 3:68417274:T:A | acceptor_gain | 1.0000 |
| 3:68417274:TGCCA:T | acceptor_loss | 1.0000 |
| 3:68417275:GCCA:G | acceptor_loss | 1.0000 |
| 3:68417276:CCA:C | acceptor_loss | 1.0000 |
| 3:68417277:CA:C | acceptor_loss | 1.0000 |
| 3:68417278:A:AC | acceptor_loss | 1.0000 |
| 3:68417278:A:AG | acceptor_gain | 1.0000 |
| 3:68417278:AGAAG:A | acceptor_gain | 1.0000 |
| 3:68417279:G:C | acceptor_loss | 1.0000 |
| 3:68417279:G:GA | acceptor_gain | 1.0000 |
| 3:68417279:GA:G | acceptor_gain | 1.0000 |
| 3:68417279:GAA:G | acceptor_gain | 1.0000 |
| 3:68417279:GAAGG:G | acceptor_gain | 1.0000 |
| 3:68417417:GATG:G | donor_gain | 1.0000 |
| 3:68417421:G:GG | donor_gain | 1.0000 |
| 3:68417421:GTA:G | donor_loss | 1.0000 |
| 3:68417422:T:A | donor_loss | 1.0000 |
| 3:68006622:A:AG | acceptor_gain | 0.9900 |
| 3:68006623:G:GG | acceptor_gain | 0.9900 |
| 3:68006623:GA:G | acceptor_gain | 0.9900 |
| 3:68006623:GAGA:G | acceptor_gain | 0.9900 |
| 3:68059160:GAC:G | donor_gain | 0.9900 |
| 3:68082870:T:TA | donor_gain | 0.9900 |
| 3:68082949:G:T | donor_gain | 0.9900 |
| 3:68218678:G:GG | donor_gain | 0.9900 |
| 3:68317277:T:TA | donor_gain | 0.9900 |
AlphaMissense
866 scored. Top likely-pathogenic:
| Variant | Protein change | am_pathogenicity |
|---|---|---|
| 3:68417291:T:A | C44S | 1.000 |
| 3:68417291:T:C | C44R | 1.000 |
| 3:68417292:G:A | C44Y | 1.000 |
| 3:68417292:G:C | C44S | 1.000 |
| 3:68417292:G:T | C44F | 1.000 |
| 3:68417293:T:G | C44W | 1.000 |
| 3:68417315:T:A | C52S | 1.000 |
| 3:68417316:G:C | C52S | 1.000 |
| 3:68417317:T:G | C52W | 1.000 |
| 3:68417319:G:A | C53Y | 1.000 |
| 3:68417345:T:C | S62P | 1.000 |
| 3:68417360:T:A | C67S | 1.000 |
| 3:68417360:T:C | C67R | 1.000 |
| 3:68417361:G:A | C67Y | 1.000 |
| 3:68417361:G:C | C67S | 1.000 |
| 3:68417361:G:T | C67F | 1.000 |
| 3:68417362:T:G | C67W | 1.000 |
| 3:68417366:T:A | C69S | 1.000 |
| 3:68417366:T:C | C69R | 1.000 |
| 3:68417367:G:A | C69Y | 1.000 |
| 3:68417367:G:C | C69S | 1.000 |
| 3:68417367:G:T | C69F | 1.000 |
| 3:68417368:T:G | C69W | 1.000 |
| 3:68417385:C:A | A75D | 1.000 |
| 3:68417387:G:A | G76R | 1.000 |
| 3:68417387:G:C | G76R | 1.000 |
| 3:68417388:G:A | G76E | 1.000 |
| 3:68417388:G:T | G76V | 1.000 |
| 3:68417405:C:T | P82S | 1.000 |
| 3:68417406:C:A | P82H | 1.000 |
dbSNP variants (sampled 300 via entrez): RS1000000515 (3:68211475 T>A), RS1000003330 (3:68008663 T>G), RS1000005102 (3:68512161 G>A), RS1000023083 (3:68518709 G>A), RS1000023653 (3:68068370 A>G), RS1000026239 (3:68083963 C>T), RS1000031604 (3:68400172 C>T), RS1000032253 (3:68014777 A>G), RS1000048106 (3:68388816 G>A,C,T), RS1000050437 (3:68337160 T>C), RS1000051093 (3:68024980 G>A), RS1000051405 (3:68211294 T>C), RS1000052155 (3:68324608 G>A), RS1000052385 (3:68251373 T>G), RS1000058304 (3:68181056 G>A,T)
Disease associations
OMIM: gene MIM:617495 | disease phenotypes:
GenCC curated gene-disease
Mondo (0):
Orphanet (0):
HPO phenotypes
0 total (0 of 0 shown, HPO-id order):
GWAS associations
7 associations (top):
| Study | Trait | p-value |
|---|---|---|
| GCST002337_118 | Amyotrophic lateral sclerosis (sporadic) | 4.000000e-07 |
| GCST006658_13 | Longevity | 3.000000e-06 |
| GCST009256_3 | Superior temporal sulcus banks volume | 5.000000e-06 |
| GCST009307_14 | Spatial memory | 7.000000e-06 |
| GCST012489_41 | Heel bone mineral density x serum urate levels interaction | 1.000000e-12 |
| GCST012490_223 | Femur bone mineral density x serum urate levels interaction | 2.000000e-10 |
| GCST012490_630 | Femur bone mineral density x serum urate levels interaction | 3.000000e-09 |
EFO canonical traits (3, from GWAS)
| EFO ID | Trait name |
|---|---|
| EFO:0004874 | memory performance |
| EFO:0004531 | urate measurement |
| EFO:0009270 | heel bone mineral density |
Drugs & pharmacology
Drug and pharmacology data
Is drug target: no
PharmGKB: 1 entry (VIP=true, CPIC=false)
CTD chemical–gene interactions
6 total (human), top 6 by PubMed support.
| Chemical | Actions (top 5) | PubMed papers |
|---|---|---|
| Valproic Acid | affects cotreatment, increases expression, decreases methylation | 2 |
| bisphenol A | decreases expression, increases methylation | 1 |
| aflatoxin B2 | increases methylation | 1 |
| CGP 52608 | affects binding, increases reaction | 1 |
| Benzo(a)pyrene | affects methylation, decreases methylation | 1 |
| Hydralazine | affects cotreatment, increases expression | 1 |
Clinical trials (associated diseases)
0 trials via MONDO — disease-level, not drug-specific.
Related Atlas pages
No linked Atlas pages yet — the cross-entity mesh grows as the corpus expands.